During the past decade, CAIMED Investigacion en Salud, S.A. de C.V. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CAIMED Investigacion en Salud, S.A. de C.V." are "Coronavirus Disease-2019 (COVID-19) Prevention" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "CAIMED Investigacion en Salud, S.A. de C.V." in a lesser frequency.

Most popular intervention types in "CAIMED Investigacion en Salud, S.A. de C.V." are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (1 trials), "Empagliflozin" (1 trials), "Linagliptin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAIMED Investigacion en Salud, S.A. de C.V." are 2 trials for "All" genders.

Currently, there are NaN active trials in "CAIMED Investigacion en Salud, S.A. de C.V.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CAIMED Investigacion en Salud, S.A. de C.V., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CAIMED Investigacion en Salud, S.A. de C.V., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".